Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:10 pm Purchase |
2021-12-31 | 13G | Merus N.V. MRUS |
Boxer Capital LLC | 1,900,000 4.400% |
300,000 (+18.75%) |
Filing History |
| 2022-01-05 9:26 pm Sale |
2022-01-03 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,717,259 10.540% |
-627,757 (-14.45%) |
Filing History |
| 2021-11-26 5:01 pm Sale |
2021-11-24 | 13D | Odonate Therapeutics, Inc. ODTC |
Boxer Capital LLC | 0 10.900% |
-0 (-8.68%) |
Filing History |
| 2021-11-22 11:08 am Sale |
2021-11-17 | 13D | Odonate Therapeutics, Inc. ODTC |
Boxer Capital LLC | 0 12.000% |
-0 (-3.35%) |
Filing History |
| 2021-09-24 4:30 pm Purchase |
2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital LLC | 6,323,359 14.900% |
6,323,359 (New Position) |
Filing History |
| 2021-07-09 4:31 pm Purchase |
2021-06-29 | 13G | Elevation Oncology, Inc. ELEV |
Boxer Capital LLC | 1,341,530 5.900% |
1,341,530 (New Position) |
Filing History |
| 2021-05-17 4:15 pm Purchase |
2021-05-07 | 13G | F-star Therapeutics, Inc. FSTX |
Boxer Capital LLC | 1,501,428 8.200% |
1,501,428 (New Position) |
Filing History |
| 2021-05-03 4:30 pm Purchase |
2021-04-27 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
Boxer Capital LLC | 1,894,192 9.990% |
1,894,192 (New Position) |
Filing History |
| 2021-04-30 4:45 pm Purchase |
2021-04-20 | 13G | Biomea Fusion, Inc. BMEA |
Boxer Capital LLC | 2,088,405 7.300% |
2,088,405 (New Position) |
Filing History |
| 2021-02-26 4:40 pm Purchase |
2021-02-17 | 13G | Talis Biomedical Corporation TLIS |
Boxer Capital LLC | 103,400 6.000% |
103,400 (New Position) |
Filing History |
| 2021-02-16 5:29 pm Purchase |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Boxer Capital LLC | 1,603,361 6.700% |
37,000 (+2.36%) |
Filing History |
| 2021-02-16 5:17 pm Sale |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
Boxer Capital LLC | 0 0.000% |
-4,425,000 (Position Closed) |
Filing History |
| 2021-02-16 5:13 pm Purchase |
2020-12-31 | 13G | Solid Biosciences Inc. SLDB |
Boxer Capital LLC | 413,351 9.900% |
199,905 (+93.66%) |
Filing History |
| 2021-02-16 5:10 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Boxer Capital LLC | 184,000 4.000% |
90,824 (+97.47%) |
Filing History |
| 2021-02-16 5:06 pm Purchase |
2020-12-31 | 13G | Atreca, Inc. BCEL |
Boxer Capital LLC | 2,202,333 7.300% |
468,750 (+27.04%) |
Filing History |
| 2021-02-16 5:01 pm Purchase |
2020-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB |
Boxer Capital LLC | 229,573 5.800% |
25,806 (+12.66%) |
Filing History |
| 2021-02-16 4:57 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,477,194 8.300% |
700,000 (+39.39%) |
Filing History |
| 2021-02-16 4:53 pm Purchase |
2020-12-31 | 13G | DBV Technologies S.A. DBVT |
Boxer Capital LLC | 188,365 6.800% |
28,750 (+18.01%) |
Filing History |
| 2021-02-16 4:50 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Boxer Capital LLC | 3,309,264 4.600% |
49,500 (+1.52%) |
Filing History |
| 2021-02-16 4:43 pm Sale |
2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
Boxer Capital LLC | 2,084,883 3.200% |
-937,508 (-31.02%) |
Filing History |